LONDON, Dec. 3, 2025 /PRNewswire/ -- Yesterday, the Sustainable Markets Initiative hosted a gathering of Heads of States and Government, the Presidents of major multilateral development banks and leading development finance institutions, and chief executives from the world's most influential banks, asset owners, insurers, alongside energy and infrastructure companies.
The shared mission is clear and urgent: to turn the transition to a sustainable global economy into the largest, most inclusive growth story of the 21st century by unleashing trillions of dollars of private capital into emerging and developing economies at speed and at scale.
This closed-door, delivery-oriented roundtable marks a decisive turning point. The models that work – guarantees at scale, originate-to-distribute, debt-for-Nature and transition swaps, blended first-loss structures and replicable blueprints – already exist and are proven.
Following the roundtable, participants attended a report back session with His Majesty The King, sharing their plans for action and the commitments they had made.
The Sustainable Markets Initiative is committed to supporting:
- Ambitious private capital mobilization ratios, scorecards and disclosure – transforming every public dollar into a powerful multiplier for private investment.
- A step-change in the scale of guarantees, political risk insurance and FX solutions, backed by deeper partnership with the global reinsurance industry.
- A predictable, securitization pipeline that the world's largest asset owners can access.
- Rapid replication of Debt-for-Nature and Debt-for-Transition swaps, with a bold new "Debt-for-Transition Accelerator" to be launched at the SMI Annual Flagship CEO Summit in March 2026.
- Standardization of approaches and blueprints so private capital can move faster and with greater confidence than ever before.
- Tech-neutral blended finance that accelerates clean energy abundance – from renewables and nuclear to grids, storage and responsible fossil fuel transition – while creating millions of new jobs and new industries.
- The systematic use of government procurement and cutting-edge AI, data and space-based monitoring to slash perceived risk and make projects bankable..
- Country transition, adaptation and resilience through our government training programme and project training toolkit.
Jennifer Jordan-Saifi, M.V.O., CEO of the Sustainable Markets Initiative, said: "The transition to a sustainable future is not a cost – it is in fact the world's greatest economic opportunity. Today we are moving decisively from billions to trillions, from pilots to systemic scale, and from talk to delivery. The private sector has already committed, and is delivering, trillions for transition by 2030. Emerging and developing economies will not be left behind – they will lead the most exciting growth story of our time, powered by private capital, AI empowered solutions, innovation and jobs."
This convening sends an unmistakable signal to markets worldwide: the era of incremental progress is over. The world's leading public and private institutions are now aligned and accelerating together. The outcomes agreed yesterday will be translated into major new commitments and initiatives at the SMI's Annual Flagship Global CEO Summit from 11-12 March 2026, heralding a new age of prosperity built on clean energy, advanced technologies, resilient infrastructure and restored Nature.
The sustainable transition is no longer a distant hope – it is the defining growth engine of the coming decade.
About the Sustainable Markets Initiative
Founded by His Majesty King Charles III, the SMI is the world's pre-eminent CEO-led coalition accelerating the transition to a sustainable future. www.sustainable-markets.org
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Sustainable Markets Initiative Hosts Landmark Private Capital Mobilization Convening in London, with a report back session attended by His Majesty King Charles III
SHANGHAI, April 2, 2026 /PRNewswire/ -- The 12th Annual China Healthcare Investment Conference (CHIC 2026) capped the first day of its two-day program with a celebratory Awards Gala Dinner held at The Ritz-Carlton Hotel Pudong, Shanghai. The evening, co-hosted by Founding Platinum Sponsor Wilson Sonsini and the BayHelix Group, recognized outstanding achievements in healthcare investment, financing, and deal-making over the past year.
This year's awards honored the companies and individuals at the forefront of China's dynamic healthcare sector — from landmark licensing and partnership agreements to capital markets milestones and private financings that are reshaping the industry. Award recipients were selected through a formal vote conducted by CHIC's Founders and 2026 Organizing Committee & Working Group, whose collective expertise spans venture capital, private equity, and global healthcare leadership.
Award Winners
IPO of the Year
Winner: Insilico Medicine
Accepted by: Leah Liu, VP and Global Head of IR & Capital Markets, Insilico Medicine
Presenter: Richard Wang, China Partner, Wilson Sonsini
Private Financing of the Year — Tied
Co-Winner: Kailera Therapeutics
Accepted by: Shelley Liu, Head of China Business Development & Strategy, Hengrui (Kailera Therapeutics was built on Hengrui assets)
Presenter: Kan Chen, Co-Head of Healthcare, Qiming Venture Partners
Co-Winner: Vor Bio
Accepted by: Jianmin Fang, CEO, RemeGen (Vor Bio's leading project is from RemeGen)
Presenter: Cyber Cao, Managing Director, HSG
Deal of the Year — Tied
Co-Winner: Hengrui Pharma – GSK
Accepted by: Shelley Liu, Head of China Business Development & Strategy, Hengrui; and Ming Fang, PhD, Senior Director, Search & Evaluation, Business Development, GSK
Presenter: Steve Yang, Co-Founder, the BayHelix Group; Co-CEO, WuXi Apptec
Co-Winner: Innovent – Takeda
Accepted by: Sophy Wang, Board Secretary & Global BD, Innovent; and Eric Yeung, Head of Oncology and Global Business Development, Takeda
Presenter: Kevin Yuan, CEO, Hankang Capital
About CHIC 2026
The China Healthcare Investment Conference (CHIC) is a premier platform connecting innovation and investment in China's healthcare sector. Now in its 12th year, CHIC brings together senior decision-makers including venture capital and private equity investors, pharmaceutical executives, and biotech and medtech CEOs. The 2026 conference was held on March 23–24 at The Ritz-Carlton Hotel Pudong, Shanghai, under the theme "Innovation in Healthcare – The Answer to Uncertainty."
About the Gala Dinner Co-Hosts
Wilson Sonsini is a leading legal advisor to life sciences, and biotechnology industries, offering integrated counsel across the full spectrum of a company's life cycle — from early-stage intellectual property strategy and patent prosecution to complex technology transactions, licensing, collaborations, as well as M&As, IPOs and capital market offerings. As Founding Platinum Sponsor of CHIC, Wilson Sonsini has been a steadfast partner in the conference's mission to connect healthcare innovation with global capital.
The BayHelix Group is a non-profit professional organization of business leaders with a mission to shape the growth of the life sciences and healthcare industry. Founded in 2001 in the San Francisco Bay Area, BayHelix has grown to over 800 members globally with a strong presence in China and the US. BayHelix serves as a co-host of the CHIC Gala Dinner and is a longstanding partner in advancing the global development of China's healthcare sector.
CHIC 2026 Founding Individuals & Organizing Committee / Working Group
The following individuals served as the voting body for the CHIC 2026 Awards, representing the CHIC Founding Individuals and the Organizing Committee & Working Group.
Founders
Marietta Wu, Managing Director, Quan Capital
Frank Kung, Managing Partner, Vivo Capital
Hongbo Lu, Managing Member, NEXTBio Capital
James Li, Venture Partner, Frazier Lifesciences
Norman Chen, CEO, The Asian American Foundation
2026 Organizing Committee & Working Group
Cyber Cao, Managing Director, HSG
Jialing Dai, President & Publisher, PharmaDJ
Tess Cameron, Managing Director, RA Capital Management
Kan Chen, Co-Head of Healthcare, Qiming Venture Partners
Sean Zhang, Executive Director, Vivo Capital
Dandan Dong, Venture Partner, TCGX
Anna Chen, Partner, Frazier Life Sciences
Yuan Yuan, Head of Platform Development, China, NEXTBio Capita
Zhanghang Yan, Vice President, Quan Capital
Yun Gao, Principal, Lilly Asia Ventures
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
CHIC 2026 Honors Landmark Deals and Financings at Annual Awards Gala
CHIC 2026 Honors Landmark Deals and Financings at Annual Awards Gala
CHIC 2026 Honors Landmark Deals and Financings at Annual Awards Gala
